Suchergebnisse - "Kralinger, Martina T"

PubPharm (28)

1

Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting : A Five-Year Follow-Up Investigation

enthalten in: Ophthalmology and therapy | 2022

von Angermann, R. | Franchi, A. | Stöckl, V. | +6

2

CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

enthalten in: Retina (Philadelphia, Pa.) | 2022

von Angermann, R. | Huber, A. | Nowosielski, Y. | +5

3

Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation

enthalten in: Ophthalmology and therapy | 2022

von Angermann, R. | Franchi, A. | Stöckl, V. | +6

4

Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation

enthalten in: Ophthalmology and therapy | 2022

von Angermann, R. | Franchi, A. | Stöckl, V. | +6

5

Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment : a monocentric register cohort study of operating room time metrics and influential factors

enthalten in: BMJ open | 2021

von Angermann, R. | Huber, A. | Hofer, M. | +4

6

Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD : a potential escape mechanism

enthalten in: Acta ophthalmologica | 2021

von Angermann, R. | Rauchegger, T. | Nowosielski, Y. | +5

7

Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration

enthalten in: Journal of ophthalmology | 2021

von Huber, A. | Angermann, R. | Nowosielski, Y. | +3

8

Systemic counterregulatory response of angiopoietin‐2 after aflibercept therapy for nAMD : a potential escape mechanism

enthalten in: Acta Ophthalmologica | 2021

von Angermann, R. | Rauchegger, T. | Nowosielski, Y. | +5

9

Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy

enthalten in: Current eye research | 2018

von Waltl, I. | Zehetner, C. | Seifarth, C. | +4

10

Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapy

enthalten in: Investigative ophthalmology & visual science | 2015

von Zehetner, C. | Bechrakis, N. | Stattin, M. | +4